Auf dieser Seite
PLSE Pulse Biosciences, Inc - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$47,90
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$12,5652-Wochen-Tief
$58,9052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$3.39B
Umsatz
$350.0K
Ihre Abzeichen
52W-Spanne
$13–$59
Analystenbewertung
BUY
Kursziel
$54
P/E
·
ROE
·
Nettogewinnmarge
-6755.8%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
PLSE Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$47.90
Marktkapitalisierung (MRQ)
$3.39B
Umsatz
$350.0K
52W-Spanne
$13–$59
PLSE Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$350.0K2020-12-31 → 2025-12-31
Freier Cashflow·2016-12-31 → 2023-12-31
Nettogewinnmarge-6755.8%2016-12-31 → 2022-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | PLSE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/S (TTM) | 2861.9 | · | 3.7 | Überbewertet | |
| K/B (MRQ) | 34.15-Jahres-Durchschnitt ≈-6.1 | ≈-6.1 | 4.0 | Überbewertet | |
| Kurs / FCF (TTM) | -55.25-Jahres-Durchschnitt ≈-10.2 | ≈-10.2 | · | · | |
| Kurs / Cashflow (TTM) | -55.55-Jahres-Durchschnitt ≈-10.3 | ≈-10.3 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 34.25-Jahres-Durchschnitt ≈12.6 | ≈12.6 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | PLSE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -7007.8% | · | 2.6% | Schwach | |
| Nettogewinnmarge (TTM) | -6755.8% | · | 2.5% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | PLSE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 9.65-Jahres-Durchschnitt ≈7.1 | ≈7.1 | 4.1 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | PLSE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -20.6% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | PLSE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$3.0K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
15.6%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-0.36 | $-0.37 | 2.0% |
| 31. März 2026 | Mai 7, 2026 | $-0.24 | $-0.32 | 25.3% |
| 31. Dezember 2025 | $-0.26 | $-0.32 | 17.8% | |
| 30. September 2025 | $-0.29 | $-0.32 | 8.3% | |
| 30. Juni 2025 | $-0.20 | $-0.27 | 24.6% | |
| 31. März 2025 | $-0.17 | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $350.0K | $0 | $0 | $700.0K | $1M | $0 | |
| Cost of Revenue | $539.0K | $0 | $0 | $12M | $2M | $0 | |
| R&D Expense | $45M | $32M | $28M | $21M | $29M | $26M | |
| SG&A Expense | $32M | $24M | $16M | $14M | $19M | $16M | |
| Operating Expenses | $77M | $56M | $44M | $59M | $64M | $50M | |
| Operating Income | $-77M | $-56M | $-44M | $-58M | $-63M | $-50M | |
| Interest Income | · | · | · | · | · | $114.0K | |
| Other Non-op | $-52.0K | $-18.0K | $1M | $-448.0K | $-646.0K | $114.0K | |
| Pretax Income | $73M | $54M | $-42M | $-59M | $-64M | $-50M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-73M | $-54M | $-42M | $-59M | $-64M | $-50M | |
| EPS (Basic) | $-1.08 | $-0.92 | $-0.85 | $-1.72 | $-2.28 | $-2.14 | |
| Shares (Basic) | 67,395,339 | 58,397,597 | 49,737,000 | 33,935,000 | 27,964,000 | 23,248,000 | |
| EBITDA | · | · | $-44M | $-58M | $-63M | $-50M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $81M | $118M | $44M | $61M | $44M | $12M | |
| Short-term Investments | · | · | · | · | · | $8M | |
| Receivables | $274.0K | $0 | · | $0 | $61.0K | · | |
| Inventory | $136.0K | $0 | · | $0 | $6M | · | |
| Prepaid Expense | $2M | $1M | $963.0K | $1M | $963.0K | $2M | |
| Current Assets | $83M | $119M | $45M | $62M | $45M | $22M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $5M | $5M | $5M | $5M | $5M | $4M | |
| Accum. Depreciation | $4M | $4M | $3M | $3M | $2M | $2M | |
| Goodwill | $3M | $3M | $3M | $3M | $3M | $3M | |
| Intangibles | $575.0K | $1M | $2M | $3M | $2M | $4M | |
| Other Non-current Assets | $691.0K | $677.0K | $365.0K | $365.0K | $365.0K | $365.0K | |
| Total Assets | $95M | $132M | $59M | $78M | $59M | $41M | |
| Accounts Payable | $3M | $2M | $2M | $2M | $2M | $2M | |
| Accrued Liabilities | $4M | $7M | $4M | $3M | $4M | $5M | |
| Short-term Debt | · | · | $0 | $917.0K | $436.0K | · | |
| Current Liabilities | $8M | $10M | $7M | $6M | $7M | $8M | |
| Capital Leases | $6M | $8M | $8M | $9M | $8M | $11M | |
| Total Liabilities | $14M | $18M | $15M | $80M | $15M | $18M | |
| Total Debt | · | · | $0 | $0 | $436.0K | · | |
| Common Stock | $68.0K | $66.0K | $55.0K | $37.0K | $55.0K | $25.0K | |
| Retained Earnings | $-463M | $-390M | $-337M | $-295M | $-337M | $-173M | |
| AOCI | · | $0 | $0 | $0 | $0 | $-1.0K | |
| Stockholders' Equity | $81M | $115M | $44M | $-2M | $44M | $23M | |
| Liabilities + Equity | $95M | $132M | $59M | $78M | $59M | $41M | |
| Shares Outstanding | 67,839,689 | 65,925,503 | 55,144,000 | 37,235,000 | 55,144,000 | 25,550,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $21M | $14M | $7M | $5M | $15M | $10M | |
| Deferred Tax | · | · | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $665.0K | $666.0K | $665.0K | $665.0K | $666.0K | $665.0K | |
| Operating Cash Flow | $-54M | $-36M | $-33M | $-47M | $-54M | $-35M | |
| CapEx | $315.0K | $125.0K | $121.0K | $401.0K | $437.0K | $441.0K | |
| Investing Cash Flow | $-335.0K | $-125.0K | $-121.0K | $-401.0K | $8M | $10M | |
| Stock Issued | · | · | $0 | $15M | $57M | $29M | |
| Net Stock Activity | · | · | $0 | $15M | $57M | · | |
| Financing Cash Flow | $17M | $110M | $16M | $80M | $63M | $31M | |
| Net Change in Cash | $-37M | $74M | $-17M | $33M | $16M | $6M | |
| Free Cash Flow | · | · | $-33M | $-47M | $-55M | $-36M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -8293.9% | -4443.9% | -43728.9% | |
| Net Margin | · | · | · | -8357.9% | -4489.4% | -43728.9% | |
| Pretax Margin | · | · | · | -8357.9% | -4489.4% | -43728.9% | |
| EBITDA Margin | · | · | · | -8293.9% | -4443.9% | -43728.9% | |
| ROA | · | · | -61.6% | -85.4% | -133.3% | -119.8% | |
| ROE | · | · | -87.5% | -2969.0% | -153.3% | -179.3% | |
| ROIC | · | · | -98.2% | 2582.6% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 6.8 | 10.4 | 4.3 | 2.9 | |
| Quick Ratio | · | · | 6.6 | 10.2 | 3.4 | 2.7 | |
| Debt / Equity | · | · | 0.0 | 0.0 | 0.0 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | 4.1 | 0.2 | · | |
| Receivables Turnover | · | · | · | 23.0 | 46.5 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | $0.80 | $-0.06 | $1.20 | $0.90 | |
| Cash / Share | · | · | $0.80 | $1.64 | $0.96 | $0.49 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -50.6% | · | · | |
| Revenue CAGR 3Y | -20.6% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $350.0K | $0 | $0 | $700.0K | $1M | $0 | |
| Net Income TTM | $-73M | $-54M | $-42M | $-59M | $-64M | $-50M | |
| Market Cap | · | · | $675M | $103M | $440M | $610M | |
| Enterprise Value | · | · | $631M | $42M | $412M | · | |
| P/S | · | · | · | 147.3 | 310.4 | · | |
| P/B | · | · | 15.2 | -45.9 | 12.3 | 26.6 | |
| P / Tangible Book | 12.1 | 10.4 | 17.0 | · | 11.1 | 37.6 | |
| P / Cash Flow | · | · | -20.4 | -2.2 | -8.1 | -17.2 | |
| P / FCF | · | · | -20.4 | -2.2 | -8.1 | -17.0 | |
| EV / EBITDA | · | · | -14.5 | -0.7 | -6.5 | · | |
| EV / FCF | · | · | -19.0 | -0.9 | -7.6 | · | |
| EV / Revenue | · | · | · | 60.0 | 290.5 | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $434.0K | $401.0K | $264.0K | $86.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-9.0K | $0 | |
| Cost of Revenue | $273.0K | $370.0K | $260.0K | $279.0K | $0 | $0 | $0 | $0 | · | · | · | $0 | $0 | $0 | $1M | $8M | |
| R&D Expense | $17M | $13M | $11M | $11M | $12M | $10M | $11M | $8M | $7M | $7M | $8M | $7M | $7M | $6M | $4M | $5M | |
| SG&A Expense | $8M | $7M | $7M | $9M | $8M | $8M | $10M | $6M | $4M | $4M | $5M | $4M | $4M | $4M | $3M | $3M | |
| Operating Expenses | $26M | $20M | $19M | $20M | $20M | $18M | $20M | $14M | $12M | $11M | $13M | $11M | $10M | $10M | $9M | $18M | |
| Operating Income | $-25M | $-19M | $-18M | $-20M | $-20M | $-18M | $-20M | $-14M | $-12M | $-11M | $-13M | $-11M | $-10M | $-10M | $-9M | $-18M | |
| Other Non-op | $15.0K | $-24.0K | $-2M | $-19.0K | $-22.0K | $-6.0K | $-838.0K | $-1.0K | $343.0K | $478.0K | $600.0K | $686.0K | $317.0K | $-239.0K | $-452.0K | $-14.0K | |
| Pretax Income | · | · | · | · | $-19M | $-17M | $88M | $-13M | $-11M | $-10M | $-12M | $-11M | $-10M | $-10M | $-9M | $-18M | |
| Income Tax | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-25M | $-19M | $-17M | $-19M | $-19M | $-17M | $-19M | $-13M | $-11M | $-10M | $-12M | $-11M | $-10M | $-10M | $-9M | $-18M | |
| EPS (Basic) | $-0.36 | $-0.27 | $-0.26 | $-0.29 | $-0.28 | $-0.25 | $-0.33 | $-0.21 | $-0.20 | $-0.18 | $-0.18 | $-0.19 | $-0.22 | $-0.26 | $-0.21 | $-0.49 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-0.49 | |
| Shares (Basic) | 69,200,020 | 67,994,566 | · | 67,385,000 | 67,275,608 | 67,125,967 | · | 61,066,000 | 57,180,000 | 57,124,000 | · | 56,866,000 | 46,086,000 | 37,390,000 | · | 37,158,000 | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 37,158,000 | |
| EBITDA | $-25M | $-19M | · | $-20M | $-20M | $-18M | · | $-14M | $-12M | $-11M | · | $-11M | $-10M | $-10M | · | $-18M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $102M | $68M | $81M | $95M | $106M | $119M | $118M | $79M | $26M | $35M | $44M | $50M | $59M | $54M | $61M | $69M | |
| Receivables | $122.0K | $157.0K | $274.0K | $15.0K | · | · | $0 | · | · | · | · | · | · | · | · | $5.0K | |
| Inventory | $236.0K | $206.0K | $136.0K | $57.0K | $51.0K | $30.0K | $0 | · | · | · | · | · | · | · | · | $750.0K | |
| Prepaid Expense | $4M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $964.0K | $963.0K | $1M | $1M | $849.0K | $1M | $1M | |
| Current Assets | $106M | $71M | $83M | $97M | $108M | $121M | $119M | $80M | $27M | $36M | $45M | $52M | $60M | $55M | $62M | $71M | |
| PP&E (Net) | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | · | · | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Goodwill | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Intangibles | $222.0K | $408.0K | $575.0K | $741.0K | $907.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| Other Non-current Assets | $403.0K | $575.0K | $691.0K | $705.0K | $677.0K | $678.0K | $677.0K | $646.0K | $714.0K | $365.0K | $365.0K | $365.0K | $365.0K | $365.0K | $365.0K | $365.0K | |
| Total Assets | $116M | $82M | $95M | $109M | $120M | $133M | $132M | $93M | $40M | $49M | $59M | $66M | $75M | $70M | $78M | $88M | |
| Accounts Payable | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | |
| Accrued Liabilities | $6M | $5M | $4M | $5M | $5M | $4M | $7M | $4M | $3M | $2M | $4M | $3M | $3M | $3M | $3M | $4M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $801.0K | $917.0K | · | |
| Current Liabilities | $11M | $10M | $8M | $10M | $9M | $8M | $10M | $7M | $6M | $5M | $7M | $5M | $6M | $7M | $6M | $7M | |
| Capital Leases | $5M | $6M | $6M | $6M | $7M | $7M | $8M | $7M | $7M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | |
| Total Liabilities | $16M | $15M | $14M | $16M | $16M | $15M | $18M | $14M | $13M | $13M | $15M | $14M | $14M | $81M | $80M | $81M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $801.0K | · | · | |
| Common Stock | $71.0K | $68.0K | $68.0K | $68.0K | $67.0K | $67.0K | $66.0K | $62.0K | $55.0K | $55.0K | $55.0K | $55.0K | $55.0K | $37.0K | $37.0K | $37.0K | |
| Retained Earnings | $-507M | $-482M | $-463M | $-446M | $-426M | $-407M | $-390M | $-371M | $-358M | $-347M | $-337M | $-325M | $-314M | $-305M | $-295M | $-286M | |
| AOCI | · | · | · | · | · | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Stockholders' Equity | $100M | $66M | $81M | $93M | $104M | $118M | $115M | $79M | $27M | $36M | $44M | $52M | $60M | $-11M | $-2M | $6M | |
| Liabilities + Equity | $116M | $82M | $95M | $109M | $120M | $133M | $132M | $93M | $40M | $49M | $59M | $66M | $75M | $70M | $78M | $88M | |
| Shares Outstanding | 70,799,962 | 68,225,067 | 67,839,689 | 67,738,000 | 67,278,000 | 67,274,000 | 65,925,503 | 61,516,000 | 55,228,000 | 55,225,000 | 55,144,000 | 54,991,000 | 54,771,000 | 37,593,000 | 37,235,000 | 37,228,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $2M | $5M | $6M | $5M | $6M | $7M | $3M | $2M | $2M | $3M | $2M | $1M | $896.0K | $748.0K | $723.0K | |
| Amort. of Intangibles | $166.0K | $167.0K | $166.0K | $166.0K | $167.0K | $166.0K | $166.0K | $167.0K | $166.0K | $167.0K | $166.0K | $166.0K | $166.0K | $167.0K | $166.0K | $166.0K | |
| Operating Cash Flow | $-19M | $-15M | $-15M | $-13M | $-13M | $-14M | $-9M | $-9M | $-8M | $-10M | $-7M | $-10M | $-9M | $-7M | $-8M | $-11M | |
| CapEx | $90.0K | $33.0K | $105.0K | $62.0K | $103.0K | $45.0K | $53.0K | $38.0K | $29.0K | $5.0K | $43.0K | $23.0K | $16.0K | $39.0K | $41.0K | $62.0K | |
| Investing Cash Flow | $-90.0K | $-33.0K | $-105.0K | $-62.0K | $-123.0K | $-45.0K | $-53.0K | $-38.0K | $-29.0K | $-5.0K | $-43.0K | $-23.0K | $-16.0K | $-39.0K | $-41.0K | $-62.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | $-29.0K | $-70.0K | |
| Financing Cash Flow | $52M | $2M | $381.0K | $2M | $0 | $15M | $48M | $62M | $-265.0K | $305.0K | $804.0K | $2M | $14M | $-432.0K | $-17.0K | $65M | |
| Net Change in Cash | $33M | $-12M | $-14M | $-11M | $-13M | $1M | $39M | $53M | $-9M | $-9M | $-6M | $-8M | $5M | $-7M | $-8M | $54M | |
| Free Cash Flow | · | $-15M | · | · | · | $-14M | · | · | · | $-10M | · | · | · | $-7M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5823.0% | -4775.6% | · | -23682.6% | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -5681.3% | -4633.7% | · | -22540.7% | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -5823.0% | -4775.6% | · | -23682.6% | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -20.9% | -17.3% | · | -19.2% | -23.9% | -18.4% | · | -16.0% | -19.8% | -17.0% | · | -13.8% | -17.2% | -17.9% | · | -23.3% | |
| ROE | -24.2% | -20.1% | · | -22.6% | -29.2% | -21.7% | · | -19.3% | -26.0% | -79.1% | · | -36.2% | -23.6% | -193.5% | · | -67.3% | |
| ROIC | · | · | · | · | -19.4% | -15.2% | · | -17.3% | -43.5% | -29.2% | · | -21.6% | -16.9% | 96.9% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.6 | 7.3 | · | 10.0 | 12.0 | 15.6 | · | 11.9 | 4.6 | 7.1 | · | 9.5 | 10.7 | 7.9 | · | 10.2 | |
| Quick Ratio | 9.3 | 7.0 | · | 9.8 | 11.8 | 15.4 | · | 11.7 | 4.4 | 6.9 | · | 9.3 | 10.5 | 7.7 | · | 9.9 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | -0.1 | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 1.9 | 3.1 | · | 0.7 | · | · | · | · | · | · | · | · | · | · | · | 3.3 | |
| Receivables Turnover | 6.7 | 4.5 | · | 8.6 | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.41 | $0.97 | · | $1.37 | $1.55 | $1.76 | · | $1.29 | $0.49 | $0.66 | · | $0.95 | $1.10 | $-0.28 | · | $0.17 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.00 | |
| Cash / Share | $1.44 | $1.00 | · | $1.41 | $1.58 | $1.77 | · | $1.28 | $0.47 | $0.63 | · | $0.92 | $1.07 | $1.44 | · | $1.86 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $751.0K | · | $86.0K | $0 | $0 | · | $0 | $0 | $0 | · | $-9.0K | $-9.0K | $256.0K | · | $2M | |
| Net Income TTM | $-80M | $-75M | · | $-75M | $-68M | $-60M | · | $-46M | $-44M | $-43M | · | $-39M | $-47M | $-51M | · | $-65M | |
| Market Cap | $1.96B | $1.47B | · | $1.20B | $1.02B | $1.08B | · | $1.08B | $618M | $481M | · | $222M | $394M | $126M | · | $86M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $171M | $335M | $73M | · | · | |
| P/S | 1656.8 | 1961.4 | · | 13941.4 | · | · | · | · | · | · | · | -24623.7 | -43755.9 | 493.4 | · | 55.1 | |
| P/B | 19.7 | 22.2 | · | 12.9 | 9.7 | 9.1 | · | 13.6 | 22.9 | 13.3 | · | 4.2 | 6.5 | -11.8 | · | 13.8 | |
| P / Tangible Book | 20.3 | 23.3 | · | 13.4 | 10.1 | 9.4 | · | 14.4 | 27.3 | 15.1 | · | 4.7 | 7.1 | · | · | 125.7 | |
| P / Cash Flow | · | -100.9 | · | · | · | -80.1 | · | · | · | -49.2 | · | · | · | -19.2 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | -19025.3 | -37228.5 | 285.2 | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $350.0K | $0 | $0 | $700.0K | $1M |
| Betriebsgewinnmarge % | · | · | · | -8293.9% | -4443.9% |
| Nettoergebnis | $-73M | $-54M | $-42M | $-59M | $-64M |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | · | · | 0.0 | 0.0 | 0.0 |
| Liquiditätsgrad | · | · | 6.8 | 10.4 | 4.3 |
| Quick Ratio | · | · | 6.6 | 10.2 | 3.4 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | · | $-33M | $-47M | $-55M |
Institutionelle Eigentümer (13F) 112 Einreicher · $293.8M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
112
Gehaltener Wert
$293.8M
Neue Positionen
19
Geschlossene Positionen
9
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 19 (-15 vs. Vorquartal) | 9 (-3 vs. Vorquartal) | 46 (+18 vs. Vorquartal) | 22 (-2 vs. Vorquartal) | +2.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $40.671.646 | 1.466.702 | 13,84% | Aktien |
| BANK OF AMERICA CORP /DE/ | $40.114.523 | 1.446.611 | 13,65% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $21.868.987 | 788.640 | 7,44% | Aktien |
| Portolan Capital Management, LLC | $20.889.924 | 753.333 | 7,11% | Aktien |
| Balyasny Asset Management L.P. | $19.908.670 | 717.947 | 6,78% | Aktien |
| CITADEL ADVISORS LLC | $17.373.233 | 626.514 | 5,91% | Aktien |
| VANGUARD GROUP INC | $15.360.341 | 1.118.743 | 5,23% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $14.873.582 | 536.276 | 5,06% | Aktien |
| STATE STREET CORP | $14.686.474 | 529.624 | 5,00% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $12.831.614 | 462.734 | 4,37% | Aktien |
| UBS Group AG | $7.644.302 | 275.669 | 2,60% | Aktien |
| GRIFFIN ASSET MANAGEMENT, INC. | $6.302.613 | 227.285 | 2,15% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4.977.452 | 179.497 | 1,69% | Aktien |
| NORTHERN TRUST CORP | $4.813.651 | 173.590 | 1,64% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.214.710 | 151.991 | 1,43% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $3.639.646 | 131.253 | 1,24% | Aktien |
| Point72 Asset Management, L.P. | $2.952.053 | 106.457 | 1,00% | Aktien |
| NORGES BANK | $2.929.591 | 105.647 | 1,00% | Aktien |
| Nuveen, LLC | $2.819.670 | 101.683 | 0,96% | Aktien |
| Panoramic Capital, LLC | $2.719.037 | 98.054 | 0,93% | Aktien |
| D. E. Shaw & Co., Inc. | $2.268.813 | 81.818 | 0,77% | Aktien |
| Westside Investment Management, Inc. | $2.156.505 | 77.768 | 0,73% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $2.071.875 | 74.716 | 0,71% | Aktien |
| SECTORAL ASSET MANAGEMENT INC | $1.882.728 | 67.895 | 0,64% | Aktien |
| Bank of New York Mellon Corp | $1.195.554 | 43.114 | 0,41% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $987.188 | 35.600 | 0,34% | Kaufoption |
| GOLDMAN SACHS GROUP INC | $953.330 | 34.379 | 0,32% | Aktien |
| Swiss National Bank | $945.593 | 34.100 | 0,32% | Aktien |
| MORGAN STANLEY | $887.221 | 31.995 | 0,30% | Aktien |
| MANGROVE PARTNERS IM, LLC | $848.871 | 30.612 | 0,29% | Aktien |
| FORMULA GROWTH LTD | $831.900 | 30.000 | 0,28% | Aktien |
| Argo Wealth Advisory, LLC | $780.766 | 28.156 | 0,27% | Aktien |
| TIAA-CREF INDIVIDUAL & INSTITUTIONAL SERVICES, LLC | $756.974 | 27.298 | 0,26% | Aktien |
| Pandora Wealth, Inc. | $706.436 | 51.452 | 0,24% | Aktien |
| DEUTSCHE BANK AG\ | $687.316 | 24.786 | 0,23% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $686.994 | 31.820 | 0,23% | Aktien |
| RHUMBLINE ADVISERS | $658.382 | 23.743 | 0,22% | Aktien |
| ALLSTATE CORP | $652.459 | 23.529 | 0,22% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $651.322 | 23.488 | 0,22% | Aktien |
| WELLS FARGO & COMPANY/MN | $598.413 | 21.580 | 0,20% | Aktien |
| WealthTrust Axiom LLC | $596.195 | 21.500 | 0,20% | Aktien |
| Creative Planning | $583.439 | 21.040 | 0,20% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $567.883 | 20.479 | 0,19% | Aktien |
| CITADEL ADVISORS LLC | $532.416 | 19.200 | 0,18% | Kaufoption |
| DIKER MANAGEMENT LLC | $527.000 | 19.000 | 0,18% | Aktien |
| Inspire Investing, LLC | $524.076 | 24.274 | 0,18% | Aktien |
| Cetera Investment Advisers | $496.755 | 17.914 | 0,17% | Aktien |
| CITADEL ADVISORS LLC | $463.091 | 16.700 | 0,16% | Verkaufsoption |
| ALLIANCEBERNSTEIN L.P. | $449.072 | 20.800 | 0,15% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $423.714 | 15.280 | 0,14% | Aktien |
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| ROBERT W. DUGGAN, GENIUS 24C INC, BLAZON CORPORATION ×18 Einreichungen | 13. Mai 2026 | 71,90% | Änderung | · | SEC |
| Christopher A. Marlett 2) ×2 Einreichungen | 26. Februar 2018 | · | Erste Einreichung | · | SEC |
| Christopher Marlett 2) | 1. Juni 2016 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 23 Insider · 9 Führungskräfte · 13 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Paul A Laviolette | Chief Executive Officer | 11. Mai 2026 P | 15.846 | 2 | 0 | $590.700 |
| Jon Skinner | Chief Financial Officer | 3. Februar 2025 A | · | 0 | 0 | $0 |
| Brian B Dow | CFO & SVP Admin. and Finance | 16. Mai 2017 A | · | 0 | 0 | $0 |
| Liane Rae Teplitsky | Chief Operating Officer | 1. September 2026 P | 4.095 | 4 | 0 | $199.942 |
| Darrin Uecker | Chief Technology Officer | 23. März 2026 A | 284.406 | 0 | 0 | $0 |
| Kevin Patrick Danahy | Chief Commercial Officer | 18. Februar 2026 M | 43.298 | 0 | 8 | $-3.017.438 |
| Steven Weber | Principal Accounting Officer | 14. Juli 2025 A | · | 0 | 0 | $0 |
| Mitchell E. Levinson | Chief Strategy Officer | 24. September 2024 X | 8.521 | 0 | 0 | $0 |
| Ed Ebbers | EVP & GM, Dermatology | 1. Juni 2021 F | 39.300 | 0 | 0 | $0 |
| Manmeet Singh Soni | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Mahkam Zanganeh | Direktor | 11. Juni 2026 A | 725.395 | 0 | 0 | $0 |
| Maria Sainz | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Richard Van Den Broek | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Robert W. Duggan | Direktor | 11. Juni 2026 A | 48.370.047 | 2 | 0 | $25.999.976 |
| Shelley D Spray | Direktor | 25. Mai 2023 A | · | 0 | 0 | $0 |
| Kenneth A Clark | Direktor | 20. Mai 2021 A | · | 0 | 0 | $0 |
| Thomas J M D Fogarty | Direktor | 16. Mai 2019 A | · | 0 | 0 | $0 |
| Thierry B. Thaure | Direktor | 16. Mai 2017 A | 0 | 0 | 0 | $0 |
| Robert J. Greenberg | Direktor | 16. Mai 2017 A | 0 | 0 | 0 | $0 |
| Robert Levande | Direktor | 16. Mai 2017 A | · | 0 | 0 | $0 |
| Burke Thomas Barrett | · | 11. Dezember 2024 S | 63.172 | 0 | 0 | $0 |
| Sandra A. Gardiner | · | 14. Dezember 2021 A | · | 0 | 0 | $0 |
| Laureen Debuono | · | 4. Oktober 2021 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 17 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,24% | 62.965 SH | 11. September 2026 | Täglich |
| ESSC · Strategy Shares | 0,15% | 1.567 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,07% | 174.265 SH | 11. September 2026 | Täglich |
| IWM · iShares Trust | 0,03% | 478.291 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 19.901 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,02% | 8.873 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 106.789 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,01% | 1.388 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 215.812 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 51.170 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 8.079 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 9.573 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 39.239 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 554.612 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.637 SH | 19. August 2026 | Täglich |
| ISCB · iShares Trust | · | 817 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 4.024 SH | 11. September 2026 | Täglich |
PLSE Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 10 Analysten
KAUF
Median-Ziel
$51.50
+7,5%
3 30,0%
Starker Kauf
6 60,0%
Kauf
1 10,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
6 Analysten · 2026-10-03Mittelwert-Ziel $54.00 +12,7%
Jetzt
Aktueller Preis $47.90
Tief$35.00
Mittelwert$54.00
Hoch$73.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| PLSE | · | · | · | · | · | · |
| ITGR | $2.69B | 27.1 | 8.0% | 5.5% | 6.0% | 27.0% |
| NVST | $3.56B | 77.5 | 8.3% | 1.7% | 1.5% | 54.7% |
| IRTC | $5.73B | -127.7 | 26.2% | -6.0% | -34.8% | 70.6% |
| ASST | · | -0.1 | 1217.5% | · | · | · |
| CHRN | $2.67B | -51.0 | -15.1% | -70.3% | -53.2% | · |
| ATRC | $1.97B | -164.8 | 14.9% | -2.1% | -2.4% | 75.0% |
| TMDX | $4.17B | 25.0 | 37.1% | 31.4% | 48.1% | 59.9% |
| BFLY | · | -12.3 | 19.0% | -79.0% | -35.9% | 46.9% |
| AXGN | $1.54B | -96.3 | 20.2% | -7.0% | -13.0% | 74.3% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Pulse Biosciences CEO kaufte 15.000 Unternehmensaktien. Hier ist, was das für Investoren bedeutet.
Yahoo Finance · 4 Monate, 2 Wochen vor
Pulse Biosciences (PLSE) meldet erste Patienten für entscheidende Vorhofflimmern-Studie an
Yahoo Finance · 5 Monate, 1 Woche vor
Pulse Biosciences ernennt Liane Teplitsky zur CCO, erweitert die Rolle von David Kenigsberg als Vollzeit-CMO
Nasdaq · 5 Monate, 3 Wochen vor
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026